Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+15.42%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$52.9B
AUM Growth
+$52.9B
(+9.6%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
27.09%
Holding
978
New
135
Increased
353
Reduced
289
Closed
117
Top Buys
| 1 |
CSX Corp
CSX
|
$218M |
| 2 |
Merck
MRK
|
$195M |
| 3 |
HES
Hess
HES
|
$171M |
| 4 |
Walmart
WMT
|
$138M |
| 5 |
Lockheed Martin
LMT
|
$102M |
Top Sells
| 1 |
Canadian Pacific Kansas City
CP
|
$231M |
| 2 |
Amgen
AMGN
|
$159M |
| 3 |
Honeywell
HON
|
$124M |
| 4 |
Domino's
DPZ
|
$124M |
| 5 |
Dover
DOV
|
$118M |
Sector Composition
| 1 | Technology | 26.41% |
| 2 | Healthcare | 17.14% |
| 3 | Financials | 11.03% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nike
NKE
$114B
| $133M | 0.25% | 1,415,161 +141,950 | +11% | +$13.3M |
|
77
RTX Corp
RTX
$212B
| $128M | 0.24% | 1,309,597 +16,742 | +1% | +$1.63M |
|
|
ERF
78
DELISTED
Enerplus Corporation
ERF
| $128M | 0.24% | 6,491,167 -351,240 | -5% | -$6.91M |
|
79
Regeneron Pharmaceuticals
REGN
$61.5B
| $127M | 0.24% | 132,138 -3,511 | -3% | -$3.38M |
|
80
Cigna
CI
$80.3B
| $125M | 0.24% | 342,820 -41,608 | -11% | -$15.1M |
|
81
Edwards Lifesciences
EW
$47.8B
| $124M | 0.23% | 1,293,963 +834,818 | +182% | +$79.8M |
|
82
Nova
NVMI
$7.74B
| $123M | 0.23% | 692,004 -501,776 | -42% | -$89M |
|
83
Eaton
ETN
$136B
| $122M | 0.23% | 391,698 -33,892 | -8% | -$10.6M |
|
84
AT&T
T
$209B
| $122M | 0.23% | 6,913,139 -32,100 | -0.5% | -$565K |
|
85
Willis Towers Watson
WTW
$31.9B
| $121M | 0.23% | 440,588 -29,700 | -6% | -$8.17M |
|
86
American Express
AXP
$231B
| $120M | 0.23% | 525,288 -23,800 | -4% | -$5.42M |
|
|
87
Amgen
AMGN
$155B
| $119M | 0.22% | 418,567 -558,017 | -57% | -$159M |
|
88
Progressive
PGR
$145B
| $119M | 0.22% | 574,085 +5,800 | +1% | +$1.2M |
|
89
Stryker
SYK
$150B
| $119M | 0.22% | 331,699 +194,669 | +142% | +$69.7M |
|
90
Booking.com
BKNG
$181B
| $119M | 0.22% | 32,700 +800 | +3% | +$2.9M |
|
91
Citigroup
C
$178B
| $118M | 0.22% | 1,866,686 +7,500 | +0.4% | +$474K |
|
92
S&P Global
SPGI
$167B
| $117M | 0.22% | 275,420 -29,300 | -10% | -$12.5M |
|
93
Travelers Companies
TRV
$61.1B
| $116M | 0.22% | 503,813 -18,000 | -3% | -$4.14M |
|
94
Morgan Stanley
MS
$240B
| $116M | 0.22% | 1,228,834 +1,100 | +0.1% | +$104K |
|
95
MoonLake Immunotherapeutics
MLTX
$3.54B
| $115M | 0.22% | 2,284,913 +759,196 | +50% | +$38.1M |
|
96
Analog Devices
ADI
$124B
| $113M | 0.21% | 572,966 -87,700 | -13% | -$17.3M |
|
97
Constellation Brands
STZ
$28.5B
| $113M | 0.21% | 416,901 -154,450 | -27% | -$42M |
|
98
Blackrock
BLK
$175B
| $112M | 0.21% | 134,228 +4,348 | +3% | +$3.62M |
|
99
O'Reilly Automotive
ORLY
$88B
| $109M | 0.21% | 96,700 -18,300 | -16% | -$20.7M |
|
100
IDEAYA Biosciences
IDYA
$2.15B
| $108M | 0.2% | 2,467,107 -457,987 | -16% | -$20.1M |
|